Thus, the present results together highlight the importance of the three targets for the antitumor effects of R001 against TNBC cell growth, cell survival, and tumor growth in a model (Fig. 7) in which STAT3, G6PD, and TrxR1 are targets of the early inhibition by R001. This evidence concerns the gene STAT3 and neoplasm.